Sudair Pharmaceutical Company
Khaled Alhasson is an experienced professional in the pharmaceutical industry, currently serving as the Chief Operating Officer at Sudair Pharmaceutical Company since February 2021. Prior to this role, Khaled held the position of Director of Operations at Hikma from October 2017 to February 2021. Khaled also contributed to Jazeera Pharmaceutical Industries as the Quality Unit Director from July 2010 to February 2021. Earlier in Khaled's career, an analyst position was held at SPEMCO from 1997 to 1998.
This person is not in any offices
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.